Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sun Pharma Advanced Research Company has enclosed the Press Release about ‘Receipt of Priority Review Voucher associated with Sezaby Approval’, which they shall be released after this intimation.
The above information is a part of company’s filings submitted to BSE.